thymalfasin
Commercial- Indications
- Hepatitis B, Hepatitis C, Cancer, Vaccine adjuvant
Company intelligence / Profile preview
NovaMed Pharmaceuticals
Pakistansec.gov ↗
- Ownership
- Private
- Employees
- ~250
- Development stage
- Commercial
01
Overview
NovaMed Pharmaceuticals manufactures high-quality generic drugs across multiple therapeutic areas. The company has been rated 'A' by the Drug Regulatory Authority of Pakistan for cGMP compliance and is ISO 9001:2008 certified.
- Therapeutic areas
- OncologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Generic drugsSolid dosage formsInjectablesNon-sterile dosage forms
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Sanofi-aventisPfizer Inc.Baxter International Inc.Bio AllianceOrexoMedaEUSA
Beyond the preview
Go deeper on NovaMed Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NovaMed Pharmaceuticals.